Naif Alghamdi

استشاري أمراض الباطنة و الكلى، مُتخصص في أمراض كبيبات الكلى و ضغط الدم. الزمالة الكندية و البورد الأمريكي، جامعة الملك عبدالعزيز و
مستشفيات د سليمان الحبيب

[Brendon Neuen @brendonneuen]

INFINITY: An IPD-meta-analysis of 14,574 patients with CKD

Finerenone reduced CKD progression, including kidney failure alone, and reduced CV events and mortality, across a broad range of glycemia, GFR, albuminuria and irrespective of SGLT2i use #ERA26

https://t.co/5RbzeRWgf8

[Naif Alghamdi @Na2ef]

@sul_59 @khalidalharkan يعطيك العافية
هنا تجي اهمية Meds reconciliation and BPMH during transition of care even in the same hospital
It is a culture that we must spread

[Merih Demiral @Merihdemiral]

☝🏼😁

[Priya Alexander, MD @MPAlexanderMD]

1/3
The diagnosis of TMA is challenging. It is really a pattern of injury. What is the etiopathogenesis? How do we treat?

Machine Learning can help.

So thrilled to share this paper, led by
@LadanZand
@MayoClinicNeph @MayoClinicPath https://t.co/EGF1Gti48D

[Saudi Society of Nephrology and Transplantation @saudi_SSN]

Join our FREE Webinar
📅 May 13, 2026 | ⏰ 9:00 PM
🎓 Earn 2 CME Credits
🔗 Register now: https://t.co/xfIZfsNjpC

@ksumedicalcity
@_KSU
@aoss1317

[Elite MedPulse @EliteMedPulse]

Two days of meaningful discussions, shared expertise, and strong engagement.

Kidmap Evolve 2026 brought together voices that matter and conversations that stayed.

[Elite MedPulse @EliteMedPulse]

A moment of recognition during the sessions.
Appreciating the expertise and perspectives brought to the stage.💫

[Naif Alghamdi @Na2ef]

جدة خضرراااااااااااااااء 💚💚💚💚💚💚💚💚

[دياريو الأهلي @diario_AFC]

🔙🌟 في مثل هذا اليوم | 24 أبريل 2016!

🏆 - الأهلي ينتصر على الهلال بنتيجة 3-1 ويحسم لقب الدوري بشكل رسمي 🟢⚪️

[Naif Alghamdi @Na2ef]

@aha_almalki @ssmfksa @B_ALMASHRAFI ايه و الله يا دكتور عبدالله.
التوقيت غريب و عجيب

[Hypertension @HyperAHA]

COMMENTARY: Resistant Hypertension Is Not Essential: It Is Primarily Aldosteronism

https://t.co/LAMVK0ppty

[Mayo Clinic Nephrology @MayoClinicNeph]

How to Manage an Adult Patient With IgA Nephropathy in the Current Era?

https://t.co/92UyjnLK3h

@LadanZand @fervenzaf @MayoProceedings

[Elite MedPulse @EliteMedPulse]

Discover Session 4 at KIDMAP Evolve 2026.
Join us for a high-impact scientific discussion on evolving immunologic therapies in glomerular disease,

The Ritz Carlton – Jeddah, Saudi Arabia
01–02 May 26
🎓 16 CME Hours AccrediteDiscover Session 4 at KIDMAP Evolve 2026.
Join us for a high-impact scientific discussion on evolving immunologic therapies in glomerular disease,

The Ritz Carlton – Jeddah, Saudi Arabia
01–02 May 26
🎓 16 CME Hours AccrediteDiscover Session 4 at KIDMAP Evolve 2026.
Join us for a high-impact scientific discussion on evolving immunologic therapies in glomerular disease,

The Ritz Carlton – Jeddah, Saudi Arabia
01–02 May 26
🎓 16 CME Hours AccrediteDiscover Session 4 at KIDMAP Evolve 2026.
Join us for a high-impact scientific discussion on evolving immunologic therapies in glomerular disease,

The Ritz Carlton – Jeddah, Saudi Arabia
01–02 May 26
🎓 16 CME Hours Accredited

[Naif Alghamdi @Na2ef]

Happy to announce that I will be talking about B cell modulating Therapies In Glomerular Diseases as a part of the KIDMAP Conference

https://t.co/rkVhOOpMv3

[Saudi Society of Nephrology and Transplantation @saudi_SSN]

Dear colleagues, we’re pleased to announce the updated date for our upcoming GN meeting:

📅 6–7 November 2026,
📍at the Crowne Plaza Hotel in Riyadh

Looking forward to your active participation! ✅

[Naif Alghamdi @Na2ef]

بإذن الله أبدأ عيادتي الأسبوعية في مستشفى الحبيب فرع المحمدية غداً الجمعة و يمكن الحجز عن طريق التطبيق.
أدام الله لكم الصحة و العافية.

[GlomCon Arabia @glomconarabia]

Join us tomorrow, April 10, 2026, on a knowledge rollercoaster road to the understanding of Targeted Therapy for C3GN by @GlomerGal

Join meeting here: https://t.co/kIt15Z5NeQ
Meeting ID: 884 4208 1901
Passcode: 100499 Visit us 👉https://t.co/9rPnSqpQR6

@GlomCon

[Naif Alghamdi @Na2ef]

@FfarisNM هبد ثم تطبيل